Announces Preclinical COVID-19 Research Tools RENSSELAER, N.Y., March 20, 2020 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces support for global COVID-19 research efforts via a new Coronavirus Toolkit featuring relevant models and services. Mouse models have been extensively used for research on the SARS-CoV virus, closely […]
Taconic Biosciences
Taconic Biosciences Launches Alzheimer’s Disease Mouse Model
Proven Model Available Exclusively From Taconic Biosciences RENSSELAER, N.Y., Nov. 04, 2019 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its robust neurodegeneration portfolio with the launch of a new Alzheimer’s disease model, the ARTE10 mouse model. Exclusively available from Taconic, the ARTE10 is a transgenic mouse model expressing mutant […]
Taconic Biosciences Announces New Scientific Advisory Board Member
Dr. Frank Sistare Joins Taconic Biosciences’ Scientific Advisory Board RENSSELAER, N.Y., Oct. 17, 2019 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the addition of Frank Sistare, PhD to its Scientific Advisory Board (SAB). Dr. Sistare joins existing SAB members Andrew Goodman, PhD, David Hill, PhD, and […]
Taconic Biosciences Licenses the Wild Mouse Gut Microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases
RENSSELAER, N.Y., April 01, 2019 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces it has obtained a license to the Wild Mouse gut microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). Investigators at the […]
Taconic Biosciences Launches New Inflammatory Bowel Disease Models
RENSSELAER, N.Y., April 19, 2018 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, announces the launch of several new inflammatory bowel disease (IBD) animal models. As a fully-licensed provider of CRISPR/Cas9 gene editing technology, Taconic scientists knocked out the mouse Il10 gene to generate a spontaneous […]
Mice in Space: Taconic Mice Included on Launch to International Space Station
HUDSON, N.Y., June 01, 2017 (GLOBE NEWSWIRE) — When the SpaceX Dragon spacecraft launches today bound for the International Space Station, they will be joined by 40 special mice, bred specifically for this mission by Taconic Biosciences, a global leader in genetically engineered mouse models and associated services. The project is a collaboration between the […]
Taconic Biosciences Announces Expansion of Key Alzheimer Animal Model
HUDSON, N.Y., May 03, 2017 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it will expand the offering of a key Alzheimer’s Disease (AD) mouse model, APPSWE – Model 1349, to include aged animals. Taconic will now offer off-the-shelf Model 1349 animals aged up to 42 […]